Montavon et al (6) and Yang et al (39) indicated that BRCA1 methylation was not associated with patient survival, however, another study demonstrated a survival disadvantage in patients whose neoplasms were methylated at BRCA1 (17). The gene discussed is BRCA1; the disease is neoplasm.